tiprankstipranks
Advertisement
Advertisement

Jaguar Animal Health Faces New Nasdaq Compliance Deficiency

Story Highlights
  • Nasdaq notified Jaguar Health on May 1, 2026 it fell below the 500,000 publicly held shares requirement after an April 30 reverse split.
  • Jaguar remains out of compliance with both bid price and share rules, raising the risk its stock could be delisted from Nasdaq if not corrected.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Jaguar Animal Health Faces New Nasdaq Compliance Deficiency

Meet Samuel – Your Personal Investing Prophet

Jaguar Animal Health ( (JAGX) ) has shared an announcement.

On May 1, 2026, Jaguar Health reported that Nasdaq staff notified the company it was out of compliance with the exchange’s minimum 500,000 publicly held shares requirement following a 1-for-35 reverse stock split effected on April 30, 2026, which left it with about 401,226 publicly held shares. The notice adds an additional basis for potential delisting and will be considered by a Nasdaq Hearings Panel, with Jaguar required to submit its views on the new deficiency by May 8, 2026.

Nasdaq staff also indicated that Jaguar remains non-compliant with both the minimum $1 bid price and publicly held shares standards until it cures the share deficiency and then maintains a closing bid of at least $1 for at least 10 consecutive trading days. The company said it is working to meet Nasdaq’s requirements, but investors face a heightened risk that Jaguar’s stock could be delisted from the exchange if compliance is not restored.

Spark’s Take on JAGX Stock

According to Spark, TipRanks’ AI Analyst, JAGX is a Neutral.

The score is held down primarily by weak financial quality (large ongoing losses and prior negative equity) and bearish technicals (price well below key moving averages with negative MACD). Corporate actions provide partial support via improved compliance and debt restructuring, but they also highlight ongoing financing/listing pressure; valuation offers limited help due to a negative P/E and no dividend.

To see Spark’s full report on JAGX stock, click here.

More about Jaguar Animal Health

Jaguar Health, Inc. is a pharmaceutical company focused on developing and commercializing prescription medicines, with its common stock listed on the Nasdaq Capital Market. The company’s shares trade under standard Nasdaq listing rules, including minimum bid price and publicly held share requirements that govern its continued inclusion on the exchange.

Average Trading Volume: 16,181

Technical Sentiment Signal: Sell

Current Market Cap: $2.68M

Find detailed analytics on JAGX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1